---
document_datetime: 2025-03-11 14:58:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/andembry-epar-all-authorised-presentations_en.pdf
document_name: andembry-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9544072
conversion_datetime: 2025-12-27 17:24:49.516976
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------------------|---------------------------|-------------------------------------------|
| EU/1/24/1885/001 | ANDEMBRY          | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                    | 1.2 ml (167 mg/ml)        | 1 pre-filled syringe                      |
| EU/1/24/1885/002 | ANDEMBRY          | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                    | 1.2 ml (167 mg/ml)        | 3 (3 x 1) pre-filled syringes (multipack) |
| EU/1/24/1885/003 | ANDEMBRY          | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1.2 ml (167 mg/ml)        | 1 pre-filled pen                          |
| EU/1/24/1885/004 | ANDEMBRY          | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 1.2 ml (167 mg/ml)        | 3 (3 x 1) pre-filled pens (multipack)     |